Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Ceramide and the induction of apoptosis.
    W D Jarvis, S Grant and R N Kolesnick
    Clin Cancer Res January 1 1996 2 (1) 1-6;

  • Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.
    S M Witherspoon, D L Emerson, B M Kerr, T L Lloyd, W S Dalton and P S Wissel
    Clin Cancer Res January 1 1996 2 (1) 7-12;

  • Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor.
    A Cuartero-Plaza, E Martínez-Miralles, R Rosell, C Vadell-Nadal, M Farré and F X Real
    Clin Cancer Res January 1 1996 2 (1) 13-20;

  • Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.
    D Ockert, V Schirrmacher, N Beck, E Stoelben, T Ahlert, J Flechtenmacher, E HagmĂ¼ller, R Buchcik, M Nagel and H D Saeger
    Clin Cancer Res January 1 1996 2 (1) 21-28;

  • Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.
    J H Schiller, M Pugh, J M Kirkwood, D Karp, M Larson and E Borden
    Clin Cancer Res January 1 1996 2 (1) 29-36;

  • Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.
    F A Sinicrope, R Pazdur and B Levin
    Clin Cancer Res January 1 1996 2 (1) 37-41;

  • Limited sampling model for area under the concentration time curve of total topotecan.
    H Minami, J H Beijnen, J Verweij and M J Ratain
    Clin Cancer Res January 1 1996 2 (1) 43-46;

  • Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death.
    V Calvez, O Rixe, P Wang, R Mouawad, C Soubrane, A Ghoumari, O Verola, D Khayat and F Colbère-Garapin
    Clin Cancer Res January 1 1996 2 (1) 47-51;

  • Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
    M S Khil, J H Kim, C A Mullen, S H Kim and S O Freytag
    Clin Cancer Res January 1 1996 2 (1) 53-57;

  • Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer.
    R Philip, B Clary, E Brunette, L Kilinski, D Murugesh, M Sorich, J Yau, J Lebkowski, H K Lyerly and M Philip
    Clin Cancer Res January 1 1996 2 (1) 59-68;

  • A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro.
    A Smith, M Hum, N J Winick and B A Kamen
    Clin Cancer Res January 1 1996 2 (1) 69-73;

  • Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.
    P G Kasprzyk, T L Sullivan, J D Hunt, C T Gubish, C A Scoppa, M Oelkuct, R Bird, P H Fischer, J M Siegfried and C R King
    Clin Cancer Res January 1 1996 2 (1) 75-80;

  • Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique.
    C L Tyer, J J Vredenburgh, M Heimer, W P Peters and R C Bast Jr
    Clin Cancer Res January 1 1996 2 (1) 81-86;

  • Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    M J Maeurer, D Martin, E Elder, W J Storkus and M T Lotze
    Clin Cancer Res January 1 1996 2 (1) 87-95;

  • Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents.
    J M Anderson, L M Heindl, P A Bauman, C W Ludi, W S Dalton and A E Cress
    Clin Cancer Res January 1 1996 2 (1) 97-105;

  • Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    J A Houghton, P J Cheshire, J D Hallman 2nd, L Lutz, X Luo, Y Li and P J Houghton
    Clin Cancer Res January 1 1996 2 (1) 107-118;

  • Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    J Cerutti, F Trapasso, C Battaglia, L Zhang, M L Martelli, R Visconti, M T Berlingieri, J A Fagin, M Santoro and A Fusco
    Clin Cancer Res January 1 1996 2 (1) 119-126;

  • Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    J N Myers, S Yasumura, Y Suminami, H Hirabayashi, W c Lin, J T Johnson, M T Lotze and T L Whiteside
    Clin Cancer Res January 1 1996 2 (1) 127-135;

  • Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
    S Takahashi, A Alcaraz, J A Brown, T J Borell, J F Herath, E J Bergstralh, M M Lieber and R B Jenkins
    Clin Cancer Res January 1 1996 2 (1) 137-145;

  • Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
    W Domagala, M Markiewski, B Harezga, A Dukowicz and M Osborn
    Clin Cancer Res January 1 1996 2 (1) 147-154;

  • p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
    H Pappot, D Francis, N BrĂ¼nner, J Grondahl-Hansen and K Osterlind
    Clin Cancer Res January 1 1996 2 (1) 155-160;

  • Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    P Lai, H Rabinowich, P A Crowley-Nowick, M C Bell, G Mantovani and T L Whiteside
    Clin Cancer Res January 1 1996 2 (1) 161-173;

  • Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
    A Bellacosa, G Almadori, S Cavallo, G Cadoni, J Galli, G Ferrandina, G Scambia and G Neri
    Clin Cancer Res January 1 1996 2 (1) 175-180;

  • Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer.
    P R Palan, M S Mikhail, G L Goldberg, J Basu, C D Runowicz and S L Romney
    Clin Cancer Res January 1 1996 2 (1) 181-185;

  • Biological and molecular analysis of a low-grade recurrence of a glioblastoma multiforme.
    A C Scheck, J R Shapiro, S W Coons, S A Norman and P C Johnson
    Clin Cancer Res January 1 1996 2 (1) 187-199;

  • Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features.
    B J Simpson, A D Ramage, M J Hulme, D J Burns, D Katsaros, S P Langdon and W R Miller
    Clin Cancer Res January 1 1996 2 (1) 201-206;

  • Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
    P Tagliaferri, G Tortora, R Guarrasi, V Damiano, A Ruggiero, D Morelli, M Caraglia, R Bianco, G di Isernia, S Pepe, C L Arteaga, B C Langton-Webster, A R Bianco and F Ciardiello
    Clin Cancer Res January 1 1996 2 (1) 207-214;

  • Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.
    J J Chiu, M K Sgagias and K H Cowan
    Clin Cancer Res January 1 1996 2 (1) 215-221;

  • Endometrial carcinoma and tamoxifen: clearing up a controversy.
    M Andersson, H H Storm and H T Mouridsen
    Clin Cancer Res January 1 1996 2 (1) 223-224;

Back to top
PreviousNext
January 1996
Volume 2, Issue 1
  • Table of Contents

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement